Samsung Electronics, a world leader in advanced semiconductor technology, today introduced its image sensor brand ‘ISOCELL®’ as well as demonstrated leading-edge solutions at the 2017 Mobile World Congress (MWC) Shanghai.
Samsung’s brand for its image sensor lineup is named after the company’s own ISOCELL technology, which is the optimum solution for today’s devices that require ultra-slim designs with high quality cameras. First introduced in 2013, ISOCELL technology separates each pixel with a physical barrier that reduces color crosstalk among pixels. This allows high color fidelity, enabling excellent image quality even with smaller pixels.
Samsung ISOCELL is underlined by four technological sub-brands—Bright, Fast, Slim and Dual—that respond to specific market demands:
“Samsung ISOCELL is a brand that represents the essence of our leading pixel technologies. We expect the ISOCELL brand to help consumers easily acknowledge and confide in camera performance as well as overall quality of the device,” said Ben Hur, Vice President of System LSI marketing at Samsung Electronics. “With our advanced image sensor technologies, Samsung will continue to bring innovation to cameras used in smartphones and other applications.”
At MWC Shanghai, Samsung will be featuring advanced logic solutions, including the Exynos 9 series with 10-nanometer FinFET process technology, for a wide range of platforms such as mobile, Virtual Reality (VR) and wearable devices.
Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…
The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…
More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…
The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…
Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…
This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…